Member Info for vanvagabond

Join the free trial on LSE. Then PM me and I'll reply. you will also find the L2 on here an eye opener.

Good find - look at the main sponsor harmony, look how many they do (albeit predominantly US) which we are swerving. To get a slice of that plus NHS .....do the math! Transformational.

18.75% spread , buys out weighing sells....if I was cynical I'd think some games were afoot....

Two things I've taken from this: "Routine contact with hospital staff" = targeting NHS "it will create a world in which all pregnant women can have accurate and safe information about their pregnancy." = targeting NHS The role will be varied, with a combination of office based clinical administration work (~70%) and field based data monitoring work (~30%). There will be no direct contact with patients but the successful applicant will have routine contact with hospital staff (i.e. Research midwives and consultants) About Premaitha Health Ltd Premaitha uses leading cutting edge technology in the field of diagnostics to bring a new product to market. Premaitha's vision is that by making it's technology widely available to testing laboratories, it will create a world in which all pregnant women can have accurate and safe information about their pregnancy. Premaitha Health is lead by experienced and dynamic Executive and Non-Executive teams, with a wealth of expertise in developing and commercialising molecular diagnostics. The field of Fetal Medicine is a fast, friendly environment to work in and the successful applicant will join a small, hardworking team of friendly and sociable staff.

Hope it comes good mate. What's your break even?

Hello buddy, help you are well. Feel for ya re the losses, never good. The ONLY person left from the old set up is Mark C, the others have all gone. It's terrible what the old co did but please try and ring fence that in your head - it's gone. Reynolds is a top top business man and put his own money in - he has said to SFU that it's the best deal he has done and if u look at his track record that is a bold statement! I sincerely hope this gets ya some of your bugs bunny back.

...if you are a muppet who bought at 120. I've got me hands up....

Everyone got what they were entitled to. the surplus requested will be shared out pro rata.

Oversubscribed !

Any more jokes like that and your getting reported.....!

!

I've topped up, brilliant entry price. Here's is a message from CEO: (from a few weeks back) "Directors and internal operating teams are very positive on current position. I spoke to Nigel Wray this morning, who is one of our main shareholders, and he is also very happy (and understands that small sellers in companies of our market cap, can cause disproportionate price moves). The business is growing fast, we’ve got a great team, and I’d like to think the economy and consumer behaviour is beginning to improve."

PMd ya.

The study, which launched on 1 November 2013, will involve the recruitment of women from several maternity units in London and South East England. It will investigate how NIPT compares with the NHS’s current Down syndrome screening programme in terms of how many women want it; how easily the NHS can provide it and how the associated information and education would be provided to women and healthcare professionals. The launch of the study created considerable media interest, some of which can be accessed via the links below. http://www.bbc.co.uk/news/health-24755589 http://www.itv.com/news/update/2013-11-01/downs-syndrome-blood-test-to-be-trialled-in-nhs/

I'll be honest I'm not arsed about their target price. Just imagine what will happen to this share when the first inkling,the first snifter of NHS involvement is confirmed. Transformational.

I keep revisiting these two sources of info: http://www.telegraph.co.uk/health/healthnews/10676672/Downs-syndrome-screening-NHS-could-soon-offer-far-more-reliable-test-for-pregnant-women.html Reference to our running the study: http://www.osprea.ox.ac.uk/wp-content/uploads/2013/07/PIL_kelly_v5-0_6mar14.docx

Did u manage to speak to him in the end?

will try and put something more cohesive together but doing research last night. is it a coincidence that we announce our new direction just after the RAPID study is concluded? The summary of the study is that its cost neutral at present - however, as this is important, its based solely on DS not the combined tests we can do in one hit. And its cost neutral based on a whopping £500 !!!! We smash that price - ergo I can see this being at standard early stage test across the spectrum for pregnancies

Detection of Down syndrome by maternal plasma DNA testing will alter the way that prenatal diagnosis and screening is delivered in the UK, both in the NHS and the private sector. It will have significant implications for some existing services such that clinical biochemistry serum screening laboratories and cytogenetic and molecular genetics laboratories can expect a fall in the number of samples. Since women are already accessing these tests, all obstetricians should have knowledge of the counselling issues involved. In addition, major NHS health policy decisions are required. In time, this technology is likely to become the primary screen for chromosomal abnormalities in pregnancy. This will enhance the information available to pregnant women while greatly reducing the loss of uncomplicated pregnancies as a result of miscarriage caused by unnecessary invasive procedures http://www.rcog.org.uk/files/rcog-corp/SIP_15_04032014.pdf

http://www.rcog.org.uk/news/non-invasive-prenatal-testing-likely-become-primary-screening-method-pregnancy-states-paper-exp